Zhang Ximei, Zhang Baozhong, Zang Fenglin, Zhao Lujun, Yuan Zhiyong, Wang Ping
Department of Radiation Oncology, Tianjin Medical University, Tianjin, People's Republic of China.
Department of Pathology, Cancer Institute and Hospital, Tianjin Medical University, Tianjin, People's Republic of China.
Onco Targets Ther. 2016 May 27;9:3181-5. doi: 10.2147/OTT.S95128. eCollection 2016.
Data on breast squamous cell carcinoma (SCC) are rare. The aim of this study was to analyze the clinical characteristics and to explore the rational treatment of patients with breast SCC.
We conducted a retrospective review of breast SCC cases treated at our center from 1966 to 2014. The majority of these patients received primary surgery followed by adjuvant chemoradiotherapy, whilst four elderly patients had lumpectomy only.
Patients with breast SCC were usually women, and large masses, large proportion of early stage disease, low levels of estrogen receptor expression, less frequent axillary lymph nodes involvement, and unfavorable prognosis were common. The 5-year overall survival and progression-free survival of all patients were 67.2% and 57.8%, respectively. Axillary nodal involvement was a significant prognostic factor for survival.
The current results indicated that breast SCC is clinically aggressive and the outcomes were poor. Distant metastasis was the main failure pattern. New strategies will be needed because of the poor outcomes.
关于乳腺鳞状细胞癌(SCC)的数据很少。本研究的目的是分析其临床特征并探索乳腺SCC患者的合理治疗方法。
我们对1966年至2014年在本中心接受治疗的乳腺SCC病例进行了回顾性分析。这些患者大多数接受了原发手术,随后进行辅助放化疗,而4名老年患者仅接受了肿块切除术。
乳腺SCC患者通常为女性,常见表现为肿块较大、早期疾病比例高、雌激素受体表达水平低、腋窝淋巴结受累频率较低以及预后不良。所有患者的5年总生存率和无进展生存率分别为67.2%和57.8%。腋窝淋巴结受累是生存的一个重要预后因素。
目前的结果表明,乳腺SCC在临床上具有侵袭性,预后较差。远处转移是主要的失败模式。由于预后不佳,需要新的治疗策略。